Assessment of Heart Tissue in Survivors of Hodgkin Lymphoma

Protocol
14-017
Full Title
Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors
Purpose

Heart disease is common among people cured of Hodgkin lymphoma, because the radiation therapy to the chest and the chemotherapy drugs used in treatment can damage the heart. Heart disease can be stopped or slowed if it is found early. Echocardiography, an ultrasound examination of the heart, is the standard approach used to monitor heart function in Hodgkin lymphoma survivors. It visualizes how the heart is moving. Stress echocardiography tests heart motion at rest, as well as how it changes with exercise.

In this study, researchers are assessing the use of cardiac magnetic resonance imaging (MRI), a new test that goes beyond heart function to examine tissue changes in heart muscle. They want to know how cardiac MRI and stress echocardiography perform in detecting the early signs of heart disease in survivors of Hodgkin lymphoma. Participants will have both tests and the results will be compared.

Co-Investigators

Weinsaft, Jonathan, MD

Eligibility

This study includes patients who were treated for Hodgkin lymphoma with chest radiation therapy at Memorial Sloan Kettering who completed treatment five or more years before entering the study and were age 18 or older at the time they were diagnosed.

For more information about this study, please contact Dr. Matthew Matasar at 212-639-8889.

Disease(s)
Lymphoma: Hodgkin's Disease
Survivorship
Locations
Related Diseases